Michael P Cooke Net Worth & Insider Trades
Michael P Cooke - Chief Scientific Officer, Magenta Therapeutics, Inc
What is Michael P Cooke's Net Worth?
The current estimated net worth of Magenta Therapeutics, Inc's Chief Scientific Officer, Michael P Cooke, is estimated to be about $768.32K . Michael P Cooke owns about 240,523 units of Magenta Therapeutics, Inc common stock. In the last year at Magenta Therapeutics, Inc, Michael P Cooke has sold an estimated value of $654.33K worth.
What is Michael P Cooke's Past Insider Trading?
Michael P Cooke's largest sale order was 7,500 units , worth over $107.98K on July 2, 2019. In total, Michael P Cooke has made about 12 transactions over a year of their time at Magenta Therapeutics, Inc. Michael P Cooke usually trades in September, with the busiest year in 2019. The most recent transaction was a sale order of 7,500 units , worth over $97.52K on December 2, 2019.
Michael P Cooke
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What is Michael P Cooke's' Mailing Address?
- Mailing address is C/o Magenta Therapeutics 50 Hampshire Street Cambridge MA 02139 MA
Magenta Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|
Jason Gardner, D.Phil. | 2020 | $530,000 | - | $2,309,592 | $262,000 | $1,256 | $3,102,848 |
Jason Gardner, D.Phil. | 2019 | $515,000 | - | $903,764 | $231,750 | $487 | $1,651,001 |
John C. Davis, Jr., M.D. | 2020 | $445,376 | - | $1,153,528 | $162,000 | $1,256 | $1,762,160 |
John C. Davis, Jr., M.D. | 2019 | $417,000 | - | $345,899 | $150,120 | $502 | $913,521 |
Stephen F. Mahoney | 2020 | $70,000 | - | $1,888,655 | - | $475 | $1,959,130 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1690585/000119312521123656/d32109ddef14a.htm
What are Magenta Therapeutics, Inc's Past Insider Trades?
Magenta Therapeutics, Inc's most recent insider trade came on September 20, 2021 by Kristen Stants who sold 5,736 units worth $38.6K . In the last 3 years, insiders at Magenta Therapeutics, Inc have sold an estimated value of $4.21M and bought an estimated value of $10.45M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Jason Gardner, See Remarks, Michael P Cooke, Chief Scientific Officer, and Kristen Stants, Chief People Officer .
Magenta Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |